University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy — Little Rock, Arkansas

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma.

Sponsors: University of Arkansas.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy?

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy conducted?

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy has 4 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma.

Is University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy accredited by Crixeo Health?

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.